Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Annals of Internal Medicine
|
February 1, 1982
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
S S Legha, R S Benjamin, B Mackay, et al.
Lancet (London, England)
|
October 27, 1979
Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results
M P Andersen, P Bechsgaard, J Frederiksen, et al.
Neurology
|
May 29, 2001
Fulminant liver failure during interferon beta treatment of multiple sclerosis
E M Yoshida, S L Rasmussen, U P Steinbrecher, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1984
The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction
H J Jürgensen, J Frederiksen, M P Andersen, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1984
Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study
H J Jürgensen, M P Andersen, P Bechsgaard, et al.
Annals of Internal Medicine
|
September 1, 1980
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma
J U Gutterman, G R Blumenschein, R Alexanian, et al.
The British Journal of Ophthalmology
|
April 20, 2006
Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review
J A Sivak-Callcott, J Rootman, S L Rasmussen, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Annals of Internal Medicine
|
February 1, 1982
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
S S Legha, R S Benjamin, B Mackay, et al.
Lancet (London, England)
|
October 27, 1979
Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results
M P Andersen, P Bechsgaard, J Frederiksen, et al.
Neurology
|
May 29, 2001
Fulminant liver failure during interferon beta treatment of multiple sclerosis
E M Yoshida, S L Rasmussen, U P Steinbrecher, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1984
The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction
H J Jürgensen, J Frederiksen, M P Andersen, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1984
Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study
H J Jürgensen, M P Andersen, P Bechsgaard, et al.
Annals of Internal Medicine
|
September 1, 1980
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma
J U Gutterman, G R Blumenschein, R Alexanian, et al.
The British Journal of Ophthalmology
|
April 20, 2006
Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review
J A Sivak-Callcott, J Rootman, S L Rasmussen, et al.
Page
of 4